Shana Wingo, MD, gynecologic oncologist, Arizona Oncology, discusses the evolution of surgery in endometrial cancer.
Shana Wingo, MD
Advertisement
Articles by Shana Wingo, MD
Shana Wingo, MD, gynecologic oncologist, Arizona Oncology, discusses the use of neoadjuvant chemotherapy in the treatment of patients with ovarian cancer.
Shana Wingo, MD, gynecologic oncologist, Arizona Oncology, discusses surgical options for the treatment of patients with newly-diagnosed ovarian cancer.
Shana Wingo, MD, gynecologic oncologist, Arizona Oncology, discusses gynecologic oncology guidelines.
Shana Wingo, MD, gynecologic oncology, Arizona Oncology, discusses the advances of surgical technology in gynecologic cancers.
Shana Wingo, MD, gynecologic oncology, Arizona Oncology, discusses the various surgical approaches being explored and conducted across patients with gynecologic malignancies.
Advertisement
Latest Updated Articles
Dr. Wingo on Surgical Approaches Across Gynecologic MalignanciesPublished: April 12th 2017 | Updated:
Dr. Wingo on Advances of Surgical Technology in Gynecologic CancersPublished: May 25th 2017 | Updated:
Dr. Wingo on Gynecologic Oncology GuidelinesPublished: June 2nd 2017 | Updated:
Dr. Wingo on the Evolution of Surgery in Patients With Ovarian CancerPublished: April 23rd 2018 | Updated:
Dr. Wingo Discusses Neoadjuvant Chemotherapy in Ovarian CancerPublished: May 17th 2018 | Updated:
Dr. Wingo on the Evolution of Surgery in Endometrial CancerPublished: June 22nd 2018 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD
4
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
5